Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: Strategies and challenges;Diagnose und Prädiktive Analysen an Zytologischen und Bioptischen Tumorproben Nicht-kleinzelliger Lungenkarzinome: Aktuelle Strategien und Herausforderungen

Pneumologie

Volumn 67, Issue 4, 2013, Pages 198-204

  Herth, F J F ^a   Bubendorf, L ^b   Gutz S ^c   Morresi Hauf, A ^d   Hummel, M ^e   Junker, K ^f   Lehmann, U ^g   Petersen, I ^h   Schnabel, P A ⁱ   Warth, A ⁱ  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Robert Koch Klinik   (Germany)

^d Institut für Pathologie   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f KLINIKUM BREMEN MITTE   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER THERAPY; CYTODIAGNOSIS; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; GENE MUTATION; GENE TRANSLOCATION; LUNG NON SMALL CELL CANCER; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD;

CARCINOMA, NON-SMALL-CELL LUNG; GENETIC MARKERS; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84876125897     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0032-1326344     Document Type: Article

References (56)

1. Jemal A., Bray F., Center M. M. et al. Global cancer statistics. CA Cancer J Clin: 2011; 61 69 90
2. Warth A., Muley T., Meister M. et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol: 2012; 30 1438 1446
3. Warth A., Muley T., Herpel E. et al. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology: 2012; 61 1017 1025
4. Mok T. S. Personalized medicine in lung cancer: what we need to know. Nat Rev Clin Oncol: 2011; 8 661 668
5. Penzel R., Schirmacher P., Warth A. A Novel EML4-ALK Variant: Exon 6 of EML4 Fused to Exon 19 of ALK. J Thorac Oncol: 2012; 7 1198 1199
6. Warth A., Macher-Goeppinger S., Muley T. et al. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. Eur Respir J: 2012; 39 1437 1442
7. Kwak E. L., Bang Y. J., Camidge D. R. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med: 2010; 363 1693 1703
8. Mok T. S., Wu Y. L., Thongprasert S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med: 2009; 361 947 957
9. Soda M., Choi Y. L., Enomoto M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature: 2007; 448 561 566 (Pubitemid 47206930)
10. Rosell R., Carcereny E., Gervais R. et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol: 2012; 13 239 246
11. Penzel R., Sers C., Chen Y. et al. EGFR mutation detection in NSCLC - assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch: 2011; 458 95 98
12. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A: 1977; 74 5463 5467
13. Molina-Vila M. A., Bertran-Alamillo J., Reguart N. et al. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. J Thorac Oncol: 2008; 3 1224 1235
14. Do H., Dobrovic A. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies. Mol Cancer: 2009; 8 82
15. Fassina A., Gazziero A., Zardo D. et al. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J Clin Pathol: 2009; 62 1096 1102
16. Morinaga R., Okamoto I., Fujita Y. et al. Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer. Cancer Sci: 2008; 99 2455 2460
17. Marchetti A., Martella C., Felicioni L. et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol: 2005; 23 857 865 (Pubitemid 46224186)
18. Pao W., Ladanyi M. Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res: 2007; 13 4954 4955 (Pubitemid 47502057)
19. Pirker R., Herth F. J., Kerr K. M. et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol: 2010; 5 1706 1713
20. Thunnissen E., Kerr K. M., Herth F. J. et al. The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer: 2012; 76 1 18
21. Petersen I., Schnabel P. A. [What's new in lung pathology: minutes from the Pulmonary Pathology Working Group of the German Society of Pathology]. Pathologe: 2011; 32 351 357
22. Schnabel P. A., Petersen I., Junker K. [Current issues in pulmonary pathology: Report of the working group on pulmonary pathology of the German Society of Pathology]. Pathologe: 2012; 33 02 351 354
23. Shure D., Fedullo P. F. Transbronchial needle aspiration in the diagnosis of submucosal and peribronchial bronchogenic carcinoma. Chest: 1985; 88 49 51 (Pubitemid 15073574)
24. Kacar N., Tuksavul F., Edipoglu O. et al. Effectiveness of transbronchial needle aspiration in the diagnosis of exophytic endobronchial lesions and submucosal/peribronchial diseases of the lung. Lung Cancer: 2005; 50 221 226 (Pubitemid 41427897)
25. Micames C. G., McCrory D. C., Pavey D. A. et al. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis. Chest: 2007; 131 539 548 (Pubitemid 46280417)
26. Herth F. J., Krasnik M., Kahn N. et al. Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest: 2010; 138 790 794
27. Gellert A. R., Rudd R. M., Sinha G. et al. Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax: 1982; 37 684 687 (Pubitemid 13243959)
28. Popovich J. Jr, Kvale P. A., Eichenhorn M. S. et al. Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis: 1982; 125 521 523 (Pubitemid 12124167)
29. Hetzel J., Eberhardt R., Herth F. J. et al. Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J: 2012; 39 685 690
30. Laurent F., Latrabe V., Vergier B. et al. Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Intervent Radiol: 2000; 23 266 272
31. Levine M. S., Weiss J. M., Harrell J. H. et al. Transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in solitary pulmonary nodules. Chest: 1988; 93 1152 1155
32. Fassina A., Corradin M., Zardo D. et al. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology: 2011; 22 306 312
33. O'Neill A. C., McCarthy C., Ridge C. A. et al. Rapid needle-out patient-rollover time after percutaneous CT-guided transthoracic biopsy of lung nodules: effect on pneumothorax rate. Radiology: 2012; 262 314 319
34. Kazerooni E. A., Lim F. T., Mikhail A. et al. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology: 1996; 198 371 375 (Pubitemid 26036839)
35. Khan M. F., Straub R., Moghaddam S. R. et al. Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol: 2008; 18 1356 1363
36. Fernandez-Villar A., Gonzalez A., Leiro V. et al. [Effect of different bronchial washing sequences on diagnostic yield in endoscopically visible lung cancer]. Arch Bronconeumol: 2006; 42 278 282 (Pubitemid 44047443)
37. van der Drift M. A., van der Wilt G. J., Thunnissen F. B. et al. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest: 2005; 128 394 400 (Pubitemid 40994500)
38. Mak V. H., Johnston I. D., Hetzel M. R. et al. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax: 1990; 45 373 376 (Pubitemid 20184895)
39. Totsch M., Guzman J., Theegarten D. et al. [Bronchoalveolar lavage]. Pathologe: 2007; 28 346 353
40. Thunnissen F. B. Sputum examination for early detection of lung cancer. J Clin Pathol: 2003; 56 805 810 (Pubitemid 37386565)
41. Karahalli E., Yilmaz A., Turker H. et al. Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Respiration: 2001; 68 611 614 (Pubitemid 34062935)
42. Govert J. A., Kopita J. M., Matchar D. et al. Cost-effectiveness of collecting routine cytologic specimens during fiberoptic bronchoscopy for endoscopically visible lung tumor. Chest: 1996; 109 451 456 (Pubitemid 26058604)
43. Lee H. S., Lee G. K., Kim M. S. et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest: 2008; 134 368 374
44. Travis W. D., Brambilla E., Noguchi M. et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol: 2011; 6 244 285
45. Weihmann J., Weichert C., Petersen I. et al. [Evaluation of a cell block method in cytological diagnostics]. Pathologe: 2012; 33 553 559
46. Bubendorf L., Feicher G., Obermann P. et al. Zytopathologie, Pathologie Band 9. Berlin, Heidelberg Springer Verlag: 2011
47. Riaz S. P., Luchtenborg M., Jack R. H. et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer: 2012; 48 54 60
48. Lau K. K., Rathinam S., Waller D. A. et al. The effects of increased provision of thoracic surgical specialists on the variation in lung cancer resection rate in England. J Thorac Oncol: 2013; 8 68 72
49. Savic S., Bihl M. P., Bubendorf L. [Non-small cell lung cancer: Subtyping and predictive molecular marker investigations in cytology]. Pathologe: 2012; 33 301 307
50. Tapia C., Savic S., Bihl M. et al. [EGFR mutation analysis in non-small-cell lung cancer: Experience from routine diagnostics]. Pathologe: 2009; 30 384 392
51. Zlobec I., Raineri I., Schneider S. et al. Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens. Lung Cancer: 2010; 68 192 197
52. Savic S., Tapia C., Grilli B. et al. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer: 2008; 98 154 160
53. Bruno P., Mariotta S., Ricci A. et al. Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient. Anticancer Res: 2011; 31 4207 4210
54. Rekhtman N., Brandt S. M., Sigel C. S. et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol: 2011; 6 451 458
55. Solomon S. B., Zakowski M. F., Pao W. et al. Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis. AJR Am J Roentgenol: 2010; 194 266 269
56. Chowdhuri S. R., Xi L., Pham T. H. et al. EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Mod Pathol: 2012; 25 548 555